Reproductive endocrinology: maternal cholestasis and offspring metabolic abnormalities

Mina Desai1, Michael G Ross

  • 1David Geffen School of Medicine at UCLA, Harbor-UCLA Medical Center, 1000 West Carson Street, Torrance, CA 90502, USA.

Insights

Maternal cholestasis during pregnancy links to increased offspring adiposity and metabolic issues in humans and mice. This highlights the crucial impact of the prenatal environment on adult health outcomes.

Area of Science:

  • Reproductive biology
  • Metabolic health
  • Developmental origins of health and disease (DOHaD)

Background:

  • Maternal cholestasis, a liver disorder during pregnancy, poses risks to both mother and fetus.
  • Emerging evidence suggests prenatal exposures can influence long-term offspring health.
  • Understanding the specific impacts of cholestasis on offspring development is crucial.

Discussion:

  • This research demonstrates a significant association between maternal cholestasis and offspring adiposity.
  • Metabolic abnormalities in offspring are also linked to maternal cholestasis during gestation.
  • Findings were consistent across both human and murine models, strengthening the conclusions.

Key Insights:

  • Maternal cholestasis during pregnancy is a risk factor for offspring developing obesity.
  • Prenatal exposure to cholestasis can lead to metabolic dysregulation in offspring.
  • The in utero environment plays a critical role in determining adult metabolic health.

Outlook:

  • Further research into the mechanisms linking maternal cholestasis to offspring metabolic health is warranted.
  • This study supports the DOHaD hypothesis, emphasizing prenatal influences on adult disease.
  • Interventions targeting maternal health during pregnancy may improve long-term offspring metabolic outcomes.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...